Real-time enrollment status for this anaplastic oligodendroglioma clinical trial
Current Status
Recruiting
Checked: September 4, 2026 at 9:05 PM UTC
| NCT Number | NCT07468136 |
| Recruiting Status | Recruiting |
| Condition | Anaplastic Oligodendroglioma |
| Phase | PHASE1 |
| Target Enrollment | 33 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | June 24, 2026 (Jun 24, 2026) |
As of September 4, 2026: Clinical trial NCT07468136 is currently recruiting participants. This phase1 study for anaplastic oligodendroglioma is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07468136 is actively recruiting participants as of September 4, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07468136 was last updated Jun 24, 2026 (June 24, 2026). HelloStudys verifies this status automatically.